Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort)
ABSTRACT: Background: Real-life impact of guidelines for the management of atopic dermatitis has been poorly studied. Objective: To assess atopic dermatitis clinical control in residents of a tropical area managed according to international consensuses. Methods: Prospective study with a 24-month fol...
- Autores:
-
Sánchez Caraballo, Jorge Mario
Toro Colorado, Yuliana
Cardona Villa, Ricardo
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2017
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/31179
- Acceso en línea:
- https://hdl.handle.net/10495/31179
- Palabra clave:
- Eccema
Eczema
Quimioterapia
Drug Therapy
Dermatitis Atópica
Dermatitis, Atopic
Calidad de Vida
Quality of Life
Dermatitis
Dermatitis por Contacto
Dermatitis, Contact
Guías de Práctica Clínica como Asunto
Practice Guidelines as Topic
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc/2.5/co/
id |
UDEA2_7f4f6055c0c1cb62574d2027cf0a5625 |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/31179 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
dc.title.alternative.spa.fl_str_mv |
Impacto clínico en la vida real de las recomendaciones de las guías para el manejo de la dermatitis atópica en una población tropical (cohorte TECCEMA) |
title |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
spellingShingle |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) Eccema Eczema Quimioterapia Drug Therapy Dermatitis Atópica Dermatitis, Atopic Calidad de Vida Quality of Life Dermatitis Dermatitis por Contacto Dermatitis, Contact Guías de Práctica Clínica como Asunto Practice Guidelines as Topic |
title_short |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
title_full |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
title_fullStr |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
title_full_unstemmed |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
title_sort |
Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort) |
dc.creator.fl_str_mv |
Sánchez Caraballo, Jorge Mario Toro Colorado, Yuliana Cardona Villa, Ricardo |
dc.contributor.author.none.fl_str_mv |
Sánchez Caraballo, Jorge Mario Toro Colorado, Yuliana Cardona Villa, Ricardo |
dc.subject.decs.none.fl_str_mv |
Eccema Eczema Quimioterapia Drug Therapy Dermatitis Atópica Dermatitis, Atopic Calidad de Vida Quality of Life Dermatitis Dermatitis por Contacto Dermatitis, Contact Guías de Práctica Clínica como Asunto Practice Guidelines as Topic |
topic |
Eccema Eczema Quimioterapia Drug Therapy Dermatitis Atópica Dermatitis, Atopic Calidad de Vida Quality of Life Dermatitis Dermatitis por Contacto Dermatitis, Contact Guías de Práctica Clínica como Asunto Practice Guidelines as Topic |
description |
ABSTRACT: Background: Real-life impact of guidelines for the management of atopic dermatitis has been poorly studied. Objective: To assess atopic dermatitis clinical control in residents of a tropical area managed according to international consensuses. Methods: Prospective study with a 24-month follow-up. Clinical response was assessed with SCORAD, DLQI and a subjective scale (SS) on severity perception by the patient. Results: Two-hundred and thirty-three patients were stratified according to SCORAD: 53 had mild severity (22%), 116 moderate (49%) and 64 severe (27%). Baseline SCORAD mean was 33 (15-41), for DLQI, it was 14 (11-20), and for the subjective scale, 85% (67-99). At 6 months, there was significant reduction (p < 0.5): SCORAD 29 (14-41), DLQI 12 (8-16) and subjective scale 62% (45-80). At 2 years, SCORAD was 21 (9-34), DLQI 7 (4-10) and subjective scale 41% (27-56); only 33% achieved complete control (SCORAD < 15%, DLQI < 5, subjective scale < 20%). Conclusions: Following international guidelines’ recommendations reduces eczema severity and improves quality of life, although only 33% achieved complete control after 2 years. |
publishDate |
2017 |
dc.date.issued.none.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2022-10-09T16:47:44Z |
dc.date.available.none.fl_str_mv |
2022-10-09T16:47:44Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.citation.spa.fl_str_mv |
Sánchez J, Toro Y, Cardona R. Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort). Rev Alerg Mex. 2017;64(3):260-269Correspondence: Jorge Sánchez. jotamsc@yahoo.comRecceived: 2016-11-10Acepted: 2017-01-06 |
dc.identifier.issn.none.fl_str_mv |
0002-5151 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/31179 |
dc.identifier.doi.none.fl_str_mv |
10.29262/ram.v64i3.244 |
dc.identifier.eissn.none.fl_str_mv |
2448-9190 |
identifier_str_mv |
Sánchez J, Toro Y, Cardona R. Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort). Rev Alerg Mex. 2017;64(3):260-269Correspondence: Jorge Sánchez. jotamsc@yahoo.comRecceived: 2016-11-10Acepted: 2017-01-06 0002-5151 10.29262/ram.v64i3.244 2448-9190 |
url |
https://hdl.handle.net/10495/31179 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Rev. Alergia Mex. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc/4.0/ |
dc.format.extent.spa.fl_str_mv |
10 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Colegio Mexicano, Asma e Inmunología Clínica A.C. |
dc.publisher.group.spa.fl_str_mv |
Grupo de Alergología Clínica y Experimental (GACE) |
dc.publisher.place.spa.fl_str_mv |
Tecamachalco, México |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/1/CardonaRicardo_2018_GuidelinesAtopicDermatitis.pdf https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/2/license_rdf https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/3/license.txt |
bitstream.checksum.fl_str_mv |
02f0b5309ade705f43b512796ffee362 c0c92b0ffc8b7d22d9cf56754a416a76 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173199843000320 |
spelling |
Sánchez Caraballo, Jorge MarioToro Colorado, YulianaCardona Villa, Ricardo2022-10-09T16:47:44Z2022-10-09T16:47:44Z2017Sánchez J, Toro Y, Cardona R. Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort). Rev Alerg Mex. 2017;64(3):260-269Correspondence: Jorge Sánchez. jotamsc@yahoo.comRecceived: 2016-11-10Acepted: 2017-01-060002-5151https://hdl.handle.net/10495/3117910.29262/ram.v64i3.2442448-9190ABSTRACT: Background: Real-life impact of guidelines for the management of atopic dermatitis has been poorly studied. Objective: To assess atopic dermatitis clinical control in residents of a tropical area managed according to international consensuses. Methods: Prospective study with a 24-month follow-up. Clinical response was assessed with SCORAD, DLQI and a subjective scale (SS) on severity perception by the patient. Results: Two-hundred and thirty-three patients were stratified according to SCORAD: 53 had mild severity (22%), 116 moderate (49%) and 64 severe (27%). Baseline SCORAD mean was 33 (15-41), for DLQI, it was 14 (11-20), and for the subjective scale, 85% (67-99). At 6 months, there was significant reduction (p < 0.5): SCORAD 29 (14-41), DLQI 12 (8-16) and subjective scale 62% (45-80). At 2 years, SCORAD was 21 (9-34), DLQI 7 (4-10) and subjective scale 41% (27-56); only 33% achieved complete control (SCORAD < 15%, DLQI < 5, subjective scale < 20%). Conclusions: Following international guidelines’ recommendations reduces eczema severity and improves quality of life, although only 33% achieved complete control after 2 years.RESUMEN: Antecedentes: Se ha estudiado poco el impacto en la vida real de las guías de manejo de la dermatitis atópica.Objetivo: Evaluar el control clínico de la dermatitis atópica en residentes de un área tropical manejados conforme a los consensos internacionales.Métodos: Estudio prospectivo con seguimiento por 24 meses. La respuesta clínica fue evaluada mediante SCORAD, DLQI y una escala subjetiva (SS) de la percepción de severidad del paciente. Resultados: 233 pacientes fueron estratificados conforme el SCORAD: gravedad leve 53 (22 %), moderada 116 (49 %) y severa 64 (27 %). La media inicial del SCORAD fue de 33 (15-41), del DLQI de 14 (11-20) y de la escala subjetiva de 85 % (67-99). A los 6 meses existió reducción significativa (p < 0.5): SCORAD 29 (14-41), DLQI 12 (8-16) y escala subjetiva 62 % (45-80). A los 2 años, SCORAD (21, 9-34), DLQI (7, 4-10) y escala subjetiva (41 %, 27-56); solo 33 % consiguió control completo (SCORAD < 15 %, DLQI < 5, escala subjetiva < 20 %).Conclusiones: El apego a las guías internacionales reduce la gravedad del eccema y mejora de forma importante la calidad de vida de los pacientes con dermatitis. Sin embargo, solo 33 % de los pacientes alcanza un control completo a los 2 años de seguir las recomendacionesCOL005956710application/pdfengColegio Mexicano, Asma e Inmunología Clínica A.C.Grupo de Alergología Clínica y Experimental (GACE)Tecamachalco, Méxicoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc/4.0/Clinical impact in the real life of guidelines recommendations for atopic dermatitis in a tropical population (TECCEMA cohort)Impacto clínico en la vida real de las recomendaciones de las guías para el manejo de la dermatitis atópica en una población tropical (cohorte TECCEMA)EccemaEczemaQuimioterapiaDrug TherapyDermatitis AtópicaDermatitis, AtopicCalidad de VidaQuality of LifeDermatitisDermatitis por ContactoDermatitis, ContactGuías de Práctica Clínica como AsuntoPractice Guidelines as TopicRev. Alergia Mex.Revista Alergia México260269643ORIGINALCardonaRicardo_2018_GuidelinesAtopicDermatitis.pdfCardonaRicardo_2018_GuidelinesAtopicDermatitis.pdfArtículo de investigaciónapplication/pdf670786https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/1/CardonaRicardo_2018_GuidelinesAtopicDermatitis.pdf02f0b5309ade705f43b512796ffee362MD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8933https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/2/license_rdfc0c92b0ffc8b7d22d9cf56754a416a76MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstream/10495/31179/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/31179oai:bibliotecadigital.udea.edu.co:10495/311792022-10-09 11:47:44.527Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |